96 related articles for article (PubMed ID: 3526883)
21. Bloodstream infections due to extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae: risk factors for mortality and treatment outcome, with special emphasis on antimicrobial therapy.
Kang CI; Kim SH; Park WB; Lee KD; Kim HB; Kim EC; Oh MD; Choe KW
Antimicrob Agents Chemother; 2004 Dec; 48(12):4574-81. PubMed ID: 15561828
[TBL] [Abstract][Full Text] [Related]
22. Klebsiella bacteremia in cancer patients.
Umsawasdi T; Middleman EA; Luna M; Bodey GP
Am J Med Sci; 1973 Jun; 265(6):473-82. PubMed ID: 4718773
[No Abstract] [Full Text] [Related]
23. [Clinico-laboratory parameters of bacteremia and sepsis caused by Escherichia coli].
Skerk V; Bobinac E; Popović-Uroić T; Schönwald S
Lijec Vjesn; 1993; 115(3-4):85-9. PubMed ID: 8231622
[TBL] [Abstract][Full Text] [Related]
24. [Bacteremia and sepsis caused by Escherichia coli and other gram negative bacilli].
Falisevac J; Schönwald S; Car V
Lijec Vjesn; 1970; 92(2):149-67. PubMed ID: 4919347
[No Abstract] [Full Text] [Related]
25. Bacteremia caused by non-sporulating anaerobes in cancer patients. A 12-year experience.
Fainstein V; Elting LS; Bodey GP
Medicine (Baltimore); 1989 May; 68(3):151-62. PubMed ID: 2716514
[TBL] [Abstract][Full Text] [Related]
26. Perils of quinolone exposure in cancer patients: breakthrough bacteremia with multidrug-resistant organisms.
Rangaraj G; Granwehr BP; Jiang Y; Hachem R; Raad I
Cancer; 2010 Feb; 116(4):967-73. PubMed ID: 20052728
[TBL] [Abstract][Full Text] [Related]
27. Clinical spectrum of urine cultures positive for ESBL-producing Escherichia coli in hospitalized patients and impact on antibiotic use.
Lepeule R; Leflon-Guibout V; Vanjak D; Zahar JR; Lafaurie M; Besson C; Lefort A;
Med Mal Infect; 2014 Dec; 44(11-12):530-4. PubMed ID: 25311839
[TBL] [Abstract][Full Text] [Related]
28. Mortality and associated risk factors in consecutive patients admitted to a UK NHS trust with community acquired bacteraemia.
Hounsom L; Grayson K; Melzer M
Postgrad Med J; 2011 Nov; 87(1033):757-62. PubMed ID: 21798969
[TBL] [Abstract][Full Text] [Related]
29. Sepsis and gastrointestinal bleeding.
Altemeier WA; Fullen WD; McDonough JJ
Ann Surg; 1972 May; 175(5):759-70. PubMed ID: 4555031
[No Abstract] [Full Text] [Related]
30. A two-center review of bacteremia in the community hospital.
Haddy RI; Klimberg S; Epting RJ
J Fam Pract; 1987 Mar; 24(3):253-9. PubMed ID: 3546587
[TBL] [Abstract][Full Text] [Related]
31. Enterobacter bacteremia in the community hospital.
Haddy RI; Cecil ML; Norris LL; Markert RJ
J Fam Pract; 1991 Jun; 32(6):601-6. PubMed ID: 2040885
[TBL] [Abstract][Full Text] [Related]
32. Characteristics of early-onset neonatal sepsis caused by Escherichia coli.
Tsai CH; Chen YY; Wang KG; Chen CY; Chen CP
Taiwan J Obstet Gynecol; 2012 Mar; 51(1):26-30. PubMed ID: 22482964
[TBL] [Abstract][Full Text] [Related]
33. Causes of death in adults with acute leukemia.
Chang HY; Rodriguez V; Narboni G; Bodey GP; Luna MA; Freireich EJ
Medicine (Baltimore); 1976 May; 55(3):259-68. PubMed ID: 1063911
[TBL] [Abstract][Full Text] [Related]
34. Bacterial etiology and antibiotic resistance pattern of septicemia in HIV and non-HIV patients admitted to tertiary care hospitals, Shiraz, South of Iran.
Ghassabi F; Hashempour T; Moghadami M; Davarpanah MA; Kalani M; Chatrabnous N; Halaji M; Shahraki HR; Hadi N
Cell Mol Biol (Noisy-le-grand); 2017 Sep; 63(9):115-121. PubMed ID: 28980931
[TBL] [Abstract][Full Text] [Related]
35. Epidemiology and impact of bloodstream infections among kidney transplant recipients: A retrospective single-center experience.
Shendi AM; Wallis G; Painter H; Harber M; Collier S
Transpl Infect Dis; 2018 Feb; 20(1):. PubMed ID: 29151282
[TBL] [Abstract][Full Text] [Related]
36. Antibiotic treatment of Escherichia coli O157 infection and the risk of hemolytic uremic syndrome, Minnesota.
Smith KE; Wilker PR; Reiter PL; Hedican EB; Bender JB; Hedberg CW
Pediatr Infect Dis J; 2012 Jan; 31(1):37-41. PubMed ID: 21892124
[TBL] [Abstract][Full Text] [Related]
37. [Corticoid therapy in septicemias].
Pirvu C; Igna M; Procopan V; Gavrilă I
Med Interna (Bucur); 1971 Aug; 23(8):1001-6. PubMed ID: 4937483
[No Abstract] [Full Text] [Related]
38. [Therapeutic effects of micronomicin against severe infections in patients with hematopoietic disorders. Hanshin Infection Study Group].
Hasegawa H; Horiuchi A; Nagai K; Kanamaru A; Masaoka T; Shibata H; Kitani T; Taniguchi N; Yasunaga K; Okamoto Y
Jpn J Antibiot; 1985 Aug; 38(8):2129-38. PubMed ID: 3908733
[TBL] [Abstract][Full Text] [Related]
39. Bacteremia in a community hospital: spectrum and mortality.
Setia U; Gross PA
Arch Intern Med; 1977 Dec; 137(12):1698-1701. PubMed ID: 931477
[TBL] [Abstract][Full Text] [Related]
40. Polymicrobial septicemia in the cancer patient.
Elting LS; Bodey GP; Fainstein V
Medicine (Baltimore); 1986 Jul; 65(4):218-25. PubMed ID: 3724434
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
